These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 2389494

  • 21. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
    Guo C, Dai K, Tang T.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
    [Abstract] [Full Text] [Related]

  • 22. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG, Bergese SD, Huang EH, Vanbuskirk AM.
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract] [Full Text] [Related]

  • 23. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M.
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract] [Full Text] [Related]

  • 24. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

  • 25. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 26. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
    Chen Z, Cobbold SP, Waldmann H, Metcalfe SM.
    Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
    [No Abstract] [Full Text] [Related]

  • 27. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA, Benner R, Savelkoul HF.
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract] [Full Text] [Related]

  • 28. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW.
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [Abstract] [Full Text] [Related]

  • 29. Successful secondary heterotopic cardiac transplantation in the mouse.
    Pearson TC, Darby CR, Wood KJ.
    Transplantation; 1992 Mar; 53(3):701-3. PubMed ID: 1549874
    [No Abstract] [Full Text] [Related]

  • 30. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody.
    Aramaki O, Shirasugi N, Akiyama Y, Takayama T, Shimazu M, Kitajima M, Ikeda Y, Niimi M.
    Transplantation; 2003 Nov 15; 76(9):1305-14. PubMed ID: 14627908
    [Abstract] [Full Text] [Related]

  • 31. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW.
    Transplantation; 1995 Feb 27; 59(4):559-65. PubMed ID: 7878761
    [Abstract] [Full Text] [Related]

  • 32. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS.
    J Immunol; 1993 Dec 15; 151(12):7249-59. PubMed ID: 7903105
    [Abstract] [Full Text] [Related]

  • 33. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH, Bach JF, Chatenoud L.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract] [Full Text] [Related]

  • 34. T cell suppression in transplantation tolerance through linked recognition.
    Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H.
    J Immunol; 1996 May 15; 156(10):3602-7. PubMed ID: 8621893
    [Abstract] [Full Text] [Related]

  • 35. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF, Shelby J, Hammond EH, Greenwood JH, Anderson JL.
    Immunology; 1994 May 15; 82(1):149-53. PubMed ID: 7913913
    [Abstract] [Full Text] [Related]

  • 36. Nonresponsiveness induced in fetal pancreas allografts by pretreatment with donor spleen cells and anti-CD4 monoclonal antibodies prior to grafting.
    Thompson SC, Mandel TE.
    Transplant Proc; 1990 Apr 15; 22(2):882-3. PubMed ID: 2327031
    [No Abstract] [Full Text] [Related]

  • 37. Effect of anti-CD4, anti-NC, and anti-NK monoclonal antibody on the survival of cardiac xenografts and allografts in mice.
    Yang L, Mottram PL, Han WR, Smart YC.
    Transplant Proc; 1995 Jun 15; 27(3):2185-6. PubMed ID: 7792927
    [No Abstract] [Full Text] [Related]

  • 38. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW.
    J Surg Res; 2001 Jun 01; 98(1):59-65. PubMed ID: 11368539
    [Abstract] [Full Text] [Related]

  • 39. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts.
    Hancock WW, Sablinski T, Milford EL, Tilney NL, Atkins RC, Kupiec-Weglinski JW.
    Transplant Proc; 1990 Oct 01; 22(5):2115-6. PubMed ID: 2219313
    [No Abstract] [Full Text] [Related]

  • 40. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T, Sayegh MH, Kut JP, Hancock WW, Milford EL, Tilney NL, Kupiec-Weglinski JW.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.